FDA mandates label updates on CAR-T cancer therapies

[cafead]

via The U.S. Food and Drug Administration said on Thursday cancer therapies that use CAR-T technology will require changes to the so-called "boxed warning" to highlight the serious risk of T-cell blood cancer in patients who use these therapies.

article source